Weijia Wu

2.6k citations
33 papers · 2.1k indexed · h-index 20

Weijia Wu

31 papers receiving 2.1k citations

Peers

Weijia Wu
Comparison fields: 5 of 123
  • Physiology 1.1k
  • Immunology 598
  • Biochemistry 173
  • Biochemistry 74
  • Immunology and Allergy 65
Replace Milena Hristova with:
Milena Hristova United States
James A. Royall United States
Klaus‐Dietrich Kröncke Germany
Vincenzo Sica Italy
Rafal R. Nazarewicz United States
Revathy Senthilmohan New Zealand
Leonor Thomson Uruguay
Janis H. Jackson United States
Alberto A. Noronha-Dutra United Kingdom
James P. Fabisiak United States
Weijia Wu relative to Milena Hristova United States Milena Hristova's profile →
Citations per field
00.5×1.5×
Milena Hristova · 1×
Citations per year

Countries citing papers authored by Weijia Wu

Since Specialization
Citations

This map shows the geographic impact of Weijia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Wu more than expected).

Fields of papers citing papers by Weijia Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Wu. The network helps show where Weijia Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weijia Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weijia Wu Line = papers co-authored together Weijia Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20240
4 20217
5 20213
6 202110
7 201925
8 201912
9 201412
10 201170
11 200932
12 200953
13 200538
14 200320
15 2002411
16 2001101
17 2000239
18 2000113
19 1999229
20
Purification and Characterization of Phospholipase A(2) from the Venom of Snake Trimeresurus stejnegeri Schmidt.
19962

About Weijia Wu

Weijia Wu is a scholar working on Physiology, Cancer Research and Immunology, having authored 33 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Asthma and respiratory diseases (5 papers), Nitric Oxide and Endothelin Effects (3 papers), Smoking Behavior and Cessation (3 papers), Circular RNAs in diseases (3 papers), Biological and pharmacological studies of plants (2 papers), MicroRNA in disease regulation (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Physiology (1.1k citations), Immunology (598 citations) and Biochemistry (173 citations). Weijia Wu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Stanley L. Hazen, Yonghong Chen, Zhongzhou Shen, Clifford H. Watson, David L. Ashley, Serpil C. Erzurum, Suzy Comhair, Husam M. Abu‐Soud, A Davignon and Wei Song. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026